Snoreline

Sleep apnoea screening and home sleep tests added to staff health check-ups

Employers Medical Device

TL;DR Snoreline adds a sleep apnoea check to the health check-ups employers already pay for. Staff fill in a short questionnaire, anyone at risk gets a home sleep test that a sleep physician reads, and people who are diagnosed get linked to treatment. Employers pay per employee screened and never see individual results.

The problem

A lot of tired employees aren't short on discipline. They have a breathing problem at night.

In a Bhopal study that ran full overnight sleep tests on 958 adults, 30.5% had moderate-to-severe obstructive sleep apnoea and 10.1% had the severe form, and the worst cases were tied to diabetes, hypertension and metabolic syndrome[1]. The sample was adults accompanying hospital patients and not a national survey, but the authors conclude India's burden is higher than earlier estimates.

Most people with apnoea do not know they have it. Left untreated, it's linked to healthcare costs 2.5 times higher than in people without it[2]. Sleep labs are few and far between, and a night in one means time off work. Who has time for that?

The idea

What it does, in regulatory terms: screening and referral. Diagnosis and treatment stay with licensed doctors. Snoreline's questionnaire flags risk. The home test uses a device registered with CDSCO, and a qualified sleep physician makes any diagnosis. Snoreline makes no treatment claims of its own.

The seed pitched AI sleep coaching for employees and I reframed it. Coaching helps with habits but it can't fix a blocked airway, and this directory already has an employer sleep-coaching idea. Apnoea is common and treatable, and hardly anyone looks for it at work.

Here's how it works - at the annual check-up, each employee fills in a validated snoring and sleepiness questionnaire, and neck size, weight and blood pressure come from the check itself. People at high risk get a disposable or returnable home sleep test couriered to them. A French trial found a home jaw-movement test cut median time to diagnosis from 106 days to 15 against lab testing, with similar gains in sleepiness[3]. A sleep physician reviews results over teleconsultation and refers anyone diagnosed to CPAP or other treatment through existing providers. Snoreline then follows up at one and three months to check people are still using it.

Who pays

The employer pays, out of the HR or benefits budget that already funds annual check-ups, or a group health insurer that cares about later claims. The employee is the user. I couldn't find a public price list for home sleep tests or employer screening in India, so a fee of ₹150–400 per employee screened, with the home test priced separately, is my assumption to test.

Why now

Sleep is now a workplace complaint people actually name. In a sleep-device maker's 2025 survey of 5,000 Indians, 49% said they struggle to fall asleep at least three times a week, and 17% of women had taken sick leave over poor sleep[4]. CDSCO finalised guidance on medical device software in 2026[5], which clears up the rules for scoring tools. And home tests now match lab tests on the outcomes that matter for a lot of patients[3].

Market signal

There's no public figure for employer sleep apnoea screening in India. The bottom-up signal is the Bhopal prevalence of 30.5% for moderate-to-severe disease[1], applied to any workforce that already gets annual check-ups. The adjacent number is about 936 million adults worldwide estimated to have apnoea[2]. Treat that as context only - it says nothing about your first ten employers.

Who's already doing this

One Indian startup makes contactless under-mattress monitors for homes and hospitals, but its site doesn't offer apnoea screening[6]. A global drugmaker bought a smartphone screening company in 2022[7], which shows there's real interest in cheap screening. Hospital sleep labs and CPAP sellers run the odd camp but those are sales events in disguise. The gap is an employer-paid path from questionnaire to diagnosis to treatment, with results kept well away from HR.

How hard is it?

Difficulty Moderate (50/100)
Starting capital ₹1.2–2.2 Cr
Time to launch 6–9 months

The questionnaire is the simple bit. The real work is the medical chain - sourcing registered home-test devices, contracting sleep physicians, sorting out courier and device-return logistics, and following up so that people who are diagnosed actually start treatment and stay on it. Privacy has to be designed in from day one, because health data must never reach the employer.

Licences and approvals

Yes, this one is regulated. Snoreline screens and refers, and the devices and doctors it works with need the licences.

  • Medical device registration under the Medical Device Rules 2017, from CDSCO. Use only home-test devices and CPAP machines with valid Indian import or manufacturing registration, and check each supplier before launch.
  • CDSCO software guidance applies if any of your software scores apnoea for diagnosis, so check it before you build scoring[5].
  • Registered medical practitioners make every diagnosis. Teleconsultations follow the national Telemedicine Practice Guidelines [Requires validation: confirm the current version with your clinical partner].
  • DPDP Act compliance before the first screening. Sleep results are health data, each employee consents separately and the employer sees only group counts[8].

Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.

How AI can power this business

  • Risk triage. Combine questionnaire answers with neck size, weight and blood pressure from the check-up to rank who should get a home test first.
  • Test logistics. Track couriers and device returns, and nudge people who haven't done their test night within a week.
  • Report prep. Pull raw signals from the home-test device into a tidy summary so the sleep physician spends time on judgement, not formatting.
  • Treatment follow-up. Send reminders and spot people whose CPAP use is slipping at the one- and three-month check-ins, then pass them to a human coordinator.

AI should never make the diagnosis here. Snoreline screens and refers, and a qualified sleep physician reads every test and decides what happens next.

Want to work out the AI layer for Snoreline? Talk to Yash →

Biggest risks

Here's what can go south -

  • Treatment drop-off. If diagnosed staff never start or quit CPAP, employers see cost without benefit.
  • Privacy breach. One leak of individual results to a manager would end trust and possibly the contract.
  • Device supply. Few home-test devices may be registered in India, which could raise costs or delay launch.

Our take

I think this is a solid idea for a founder from diagnostics, a sleep clinic or a health check-up company, someone who can run a clinical network. It isn't one for a wellness-app founder who hates paperwork. Prove two things first - that at least 60% of employees flagged at high risk complete the home test, and that half of those diagnosed are on treatment at three months.

Questions founders ask

Plan for roughly ₹1.2–2.2 Cr, mostly on registered home-test devices, sleep physicians, logistics and privacy-safe software.

Do I need a licence to start a sleep apnoea screening service in India?

You need CDSCO-registered devices, registered doctors for every diagnosis and DPDP-compliant handling of health data. Screening alone does not let you diagnose.

Can I start a workplace sleep screening business in another country?

Yes, if employers there already fund health check-ups. Check your local medical device and telemedicine rules before you pick a home-test device.

Download the kit

The free Snoreline validation kit has the line-by-line capital breakdown, the effort scoring, the device, telemedicine and data-protection checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for HR teams and employees, and 5 assumptions to test. Download the kit →

Talk to Yash

Thinking about building Snoreline or something close to it? The make-or-break work is building a reliable chain of registered devices and sleep doctors, then getting diagnosed staff to stay on treatment. If you need a hand, you know where to find me. Talk to Yash →

Sources

  1. Goyal et al., "Prevalence and association analysis of obstructive sleep apnea in India: results from BLESS cohort", Sleep Medicine (Europe PMC record), 2025. https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI:10.1016/j.sleep.2024.11.029&format=json&resultType=core
  2. Zappalà et al., "The global socioeconomic burden of obstructive sleep apnea: a comprehensive review", Healthcare (Basel) (Europe PMC record), 2025. https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC12428043&format=json&resultType=core
  3. Pépin et al., "Time to diagnosis and treatment of obstructive sleep apnoea using mandibular jaw movement monitoring versus polysomnography: SUNSAS trial", Lancet Regional Health Europe (Europe PMC record), 2026. https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC13147807&format=json&resultType=core
  4. BioSpectrum India, "Global Sleep Study 2025 reveals India's growing sleep crisis" (ResMed survey), 2025-02-28. https://www.biospectrumindia.com/news/16/25776/global-sleep-study-2025-reveals-indias-growing-sleep-crisis.html
  5. Emergo by UL, "India CDSCO finalizes guidance on medical device software", 2026-07-30. https://www.emergobyul.com/news/india-cdsco-finalizes-guidance-medical-device-software
  6. Dozee, official site, accessed 2026-10-21. https://dozeehealth.ai/
  7. Sleep Review, "Pfizer acquires ResApp Health", 2022-12-09. https://sleepreviewmag.com/sleep-diagnostics/screeners/smart-phone/pfizer-acquires-resapp-health/
  8. PRS Legislative Research, "Digital Personal Data Protection Bill 2023", 2023-08. https://prsindia.org/billtrack/digital-personal-data-protection-bill-2023

For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.

Reviews

No reviews yet